FY '26 funding for major research agencies (NIH, NSF, etc.)
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- WARING FEDERAL STRATEGIES
- Client
- AUTM
- Filing UUID
- 64b2cd3b-2f98-424a-9aff-c8d6db655cb8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
S. 708 and H.R. 1534 -- RESTORE Patent Rights Act of 2025 -- issues related to injunctions for patent infringement S. 1546 and H.R. 3152 -- Patent Eligibility Restoration Act -- related to clarifications of Section 101 of patent law S. 1553 and H.R. 3160 -- PREVAIL Act (Promoting and Respecting Economically Vital American Innovation Leadership Act -- related to reforms of the Patent Trials and Appeals Board at the US Patent and Trademark Office
Literal federal measure citations: S. 708, H.R. 1534, S. 1546, H.R. 3152, S. 1553, H.R. 3160
NOT- OD - 25 - 068 --- Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
S. 853 -- INNOVATE Act -- related to re-authorization of the Small Business Innovation Research and Small Business Technology Transfer programs Discussions re: House versions of similar Senate SBIR/STTR legislation
Literal federal measure citations: S. 853
H.R. 1 -- to provide for reconciliation pursuant to title II of H. Con. Res. 14 -- provisions related to taxing litigation funding for patent cases as well as taxability of university licensing revenues -- also provisions related to Section 174 of IRS law related to taxes on Small Business Innovation Research grants
Literal federal measure citations: H.R. 1, H. Con. Res. 14
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.